Healthcare Cell Culture Media for Vaccine Market | Page 2

REPORT DESCRIPTION
Cell Culture Media for Vaccine Market – Overview
High prevalence of infectious diseases is expected to drive the market growth over the forecast period.
According to the Centers for Disease Control and Prevention (CDC), in 2017, around 9,105 tuberculosis
cases and around 42,743 cases of lyme disease were reported in the U.S. Also, according to the study
conducted by University of Oxford, 2018, the measles cases are currently high in several European
countries, where over 82,500 measles cases were registered in Europe in 2018. The number was thrice as
compared in 2017, while 15 times in comparison with 2016.
Moreover, increasing availability of innovative bovine blood plasma derivatives is expected to augment the
market growth. For instance, in April 2015, Rocky Mountain Biologicals, Inc., a life science and
bioprocessing company, launched high-performance Fetal Bovine Serum alternative — Fetalgro. Fetalgro
is a proprietary blend of a calf serum base and proprietary additive that matches the Fetal Bovine Serum’s
(FBS) cell growth capabilities in CHO, MRC-5, Vero, and a wide range of other cell lines.